|Smart. Human. Proven.||Discover GoodStart||Meet Pleio||Press Releases||Contact us|
The mission of Pleio, Inc. is to design, assemble, implement and assess cost-effective health support systems that can deliver value to patients, their families, and those who support and need them.
Pleio was developed by a group of 7 partners from Boston and Montreal in 2005. Everyone saw a pressing need to help their friends or their families follow medication regimens with more support, encouragement and feedback. The partners all shared the desire and ability to create a world-class company that would bring innovative solutions to life in the area of medication adherence.
Dozens of colleagues in marketing, telephony, informatics and healthcare as well as family and friends, helped formulate the Pleio approach: a blend of personal and virtual contact that touches the patient's emotions and intellect to enhance their comfort with important new medication regimens. The wisdom of many diverse experts, years of healthcare education experience, and months of applied research and development brought Pleio GoodStart® to life in April 2007.
It’s smart, human and proven. IT’S THE WAY HEALTHCARE SHOULD BE.
Michael Oleksiw is responsible for the company's innovative core product and customer strategies. For over 22 years, Michael has transformed and scaled emerging companies in technology, product development and marketing across healthcare and retail sectors in the US, Europe and Asia. Prior to Pleio, he served as the Global Director of Lawson Software's (Infor) PLM business where his unit achieved the highest Net Promoter (NPS) scores amongst all manufacturing industry clients. Earlier in his career, he commercialized a suite of clinical trials data management software and won awards for the development of mypatient.com CME. He was instrumental in establishing a US owned technology center in China that delivered services to the Fortune 500. While in college, Michael created an Olympic gold medal winning bespoke bicycle manufacturing company. He is graduate of the John Molson School of Business.
Dr. Bram Greenberg is a clinical physician with over twenty years of experience working in the pharmaceutical industry, having served in positions of increasing responsibility at Merck & Co., Inc. At the time he left Merck to begin a consulting practice and subsequently to join Pleio, Bram was Executive Director & Department Head in Medical Services at Merck, responsible for oversight of all of the Company's medical information and communications activities in the U.S. At Merck, Bram managed a department of highly‐educated and experienced physicians, PhDs, PharmDs, pharmacists, nurses, and education and information specialists, responsible for medical information to healthcare professionals, medical education of the entire Merck sales force in the U.S., and medical/regulatory review of Merck programs and materials. Bram also oversaw the medically‐related customer response activities provided by Merck's extensive Call Center. He also leveraged his computer science background to initiate and lead a number of key technology projects for Merck. Dr. Greenberg received his undergraduate degree, summa cum laude, in Computers & Medical Technology from the University of Pennsylvania. He went on to medical school at Drexel University College of Medicine and did a residency in Pediatrics at Jefferson Medical College. Bram holds medical licenses in NJ and PA, and is board‐certified in Pediatrics.
Michael Feldman brings over 30 years' experience in creating and developing software products with over a dozen commercial software titles to his credit ranging from video game cartridges to enterprise wide software solutions. He is a founder of three previous companies and was actively involved in several other startups. In all these endeavors, Mr. Feldman built the entire software development organization from the ground up, molding them into high performing teams that balanced business needs with technical innovation. Mr. Feldman earned a Bachelor of Arts degree from Brown University, a Master of Science in Computer Science from Rensselaer Polytechnic Institute and an MBA from the University of Connecticut. He is a member of the IEEE and the ACM and holds the PMP project management certification. He recently completed courses in Data Analysis and Computing for Data Analysis at Johns Hopkins University.
Abby Reynolds is dedicated to managing and providing a positive client experience for pharma and pharmacy partners alike. Reynolds received her doctor of pharmacy from West Virginia University in 2007. She honed her patient care and clinical skills during a post-graduate residency that she completed with the University of North Carolina and Kerr Drug. Post residency, Reynolds managed and developed clinical programs for Kerr Drug. It was during this time she was exposed to the GoodStart Program, Pleio’s cornerstone adherence program. Reynolds joined the Pleio team in early 2013 and continues to play an integral role in the implementation and management of the GoodStart Program.
Reynolds has received the Parata/Pharmacy Times Next Generation Pharmacist Rising Star of the Year Award. She has served in leadership roles for the North Carolina Association of Pharmacists and the North Carolina Alliance for Health Communities. She is an active member of these organizations as well as Alliance, as well as the American Pharmacists Association.
Geri-Lynn Kushneryk has been a contractual CFO since 2007 for many companies and in that capacity has helped set up company operations for growth, fund raising both debt and equity and has led companies to exit through acquisition. Prior to this, Geri-Lynn worked with Caisse de Dépôt et Placement du Québec ("CDP"), Canada's second largest pension fund, starting in the venture capital arm and later was involved in the successful restructuring of a portfolio of over 100 technology companies where she directly managing more than 40 of these companies. She was also a Principal of Garage Technology Ventures Canada, one of CDP's fund investments. Before joining CDP, Geri-Lynn was responsible for several domestic and international acquisition projects at Bell ActiMedia, a subsidiary of Canada's largest telecommunications carrier. She was also among a group handpicked to conceive and develop Bell Canada's B2B portal, BellZinc, an online media and e-commerce portal serving small and medium sized businesses. Geri-Lynn began her career as a chartered accountant at PricewaterhouseCoopers, where she was an advisor to various companies in the areas of restructuring, project finance and privatization. Geri-Lynn is a graduate of McGill University (Psychology) and from Concordia University (Graduate Diploma in Public Accountancy) and is a member of the Ordre des comptables agrées du Québec.
Stephanie Evans oversees the execution and implementation of the Pleio GoodStart Programs. She successfully scaled the virtual team of GoodStarters from a few to hundreds within a few months. She has created a nation-wide virtual network that is agile, nimble, and quickly scalable. Ms. Evans brings over 25 years of business development, operations management, and sales experience. She started her career in entrepreneurship at the age of 16. Before joining Pleio, as the owner of a small construction company, Ms. Evans successfully evolved it into a multi-dimensional organization, culminating in larger scale million dollar projects. Ms. Evans has professional accreditations in the construction industry, receiving design awards for some of her projects. Ms. Evans has served in leadership roles on boards at the local and state level for Soroptimist, PTA, and City Development, offering expertise in fund raising, operations, and fiscal control of multi-million dollar budgets.
Jere Doyle is a serial entrepreneur experienced in building profitable and sustainable companies into recognized industry leaders. Jere founded and launched two companies, Prospectiv and Global Marketing, leading both from the start-up phase, to highly profitable businesses and finally to successful liquidity events for all shareholders. He now operates Doyle Enterprises, and advisory firm for start-ups and growth ventures. Jere is passionate about entrepreneurship. He is experienced at building world-class executive teams, developing and launching innovative products, and building vibrant company cultures. He has a particular expertise in sales, marketing and all areas of customer acquisition. Until the summer of 2012, Jere was the CEO of Prospectiv, a highly-respected online customer acquisition company he founded in 1999 that connects the world's leading national brands and local and online businesses to new customers. In 2011, Prospectiv was acquired by the Affinion Group, the global leader in customer engagement and loyalty solutions. Jere launched Prospectiv in 1999 and built the Company into the leader in online customer acquisition. With top brands like P&G, Walmart, Pfizer, Sony and hundreds of others as clients, Prospectiv focused on serving as a valuable strategic and cost-effective marketing strategy for brands and businesses looking to acquire female customers aged 25-54. In 2010 Prospectiv launched daily deal site Eversave.com, now a leader in the social commerce marketplace. Jere received an M.B.A. from Harvard Business School following his undergraduate studies in marketing and finance at Boston College. He is currently Co-Chair of the Boston College Technology Council, is a member of Launchpad Ventures Group, and in addition to Pleio's Board serves on the Boards of Brodeur Partners, VERC Enterprises, Flashnotes, Coherent Path, Shuttersong, Keyword Advisors, Privy, Jebbit, OpenBay, Rocket Travel and Ellie Kai. Doyle also serves as an advisor to several smaller ventures and has coached many entrepreneurs.
Zorba Lieberman is an investor, advisor, and board member with various information-based companies serving mostly the pharmaceutical and healthcare industries. Mr. Lieberman was co-founder and CEO of Citeline Inc., the leading provider of global clinical trial intelligence to the pharmaceutical industry. In the mid-1990's, he cofounded and built Citizen 1 Software, which pioneered the effort to organize and mine business-relevant information from the Internet. Previously, Mr. Lieberman was in strategic and new product planning at both Genentech and Eli Lilly, and was a management consultant at The Wilkerson Group. Mr. Lieberman holds BA and MBA degrees from Cornell University, as well as a Masters in international finance from the Université Catholique de Louvain in Belgium.
Pete Sikora is a successful investor and entrepreneur with 25 years of experience serving the pharmaceutical and healthcare industries. After beginning his career in pharmaceutical sales, Pete was drawn to entrepreneurial pursuits and in 1996 joined as a ground floor employee of Citizen 1 Software, located in San Francisco's famed "multi-media gulch" in the SOMA district. After Citizen 1's successful sale to Caredata.com in 1996, Pete remained as part of the integrated company before co-founding Citeline, Inc. in 2000. Citeline is the leading provider of clinical trials competitive intelligence to the pharmaceutical industry, which led to its highly successful acquisition in 2006 by UK-based Informa, Ltd. Pete continued as President of the Citeline division through 2011, successfully guiding his company's integration before amicably departing and retiring to pursue philanthropic and investment opportunities. Pete is currently Chairman of the Sikora Family Foundation and also serves on the board of directors of the Petaluma Educational Foundation and the board of regents for St. Vincent de Paul High School in Petaluma, Ca. Pete is also a proud varsity coach of the St. Vincent de Paul Lady Mustangs fast pitch softball team, recent two-time North Coast Section Division V champions. Mr. Sikora holds a B.A. in Economics from the University of California at Davis. Pete joins the board of Pleio to leverage his vast business and industry expertise to help guide Pleio's next growth phase.
Shahir Kassam-Adams is an experienced entrepreneur and general manager with a strong track record in business development and turnarounds. Notably, he has led or managed M&A transactions valued at more than $18 billion. Most recently, Shahir was the Chief Strategy Officer for Decision Resources Group (DRG), leading the company's business development initiatives and serving on the Board of Directors. At DRG was also the interim Chief Technology Officer and President and CEO of Millennium Research Group, DRG's Toronto-based medical device business unit. Shahir was also a senior general manager Thomson Reuters and Harcourt. Shahir has been an investor and Board member for several small companies including Economic Modeling Specialists International (EMSI – acquired by Career Builder), Aileron Solutions, OpenQ, VUCA Health, MMS-Varian, and CCSI. Shahir holds a bachelor's degree from Emory University, an MBA from the Wharton School of the University of Pennsylvania and a Masters in Computer Science from The Johns Hopkins University. He has done doctoral-level graduate work at the Harvard Business School and taught undergraduate and graduate level management and technology courses at Harvard University and the University of Virginia.
Mark cofounded Pleio in 2006. Prior to Pleio, he founded, built and successfully sold two information database companies, Legal Support Systems and Database Publishing Group. Before becoming an entrepreneur, Mark worked as a strategy consultant for Deloitte & Touche in its Boston office. He holds an MBA from the Harvard Business School. Before business school, he served in the Army as acting commander of a 210-person engineer company, earned a Masters in Engineering Administration at George Washington University, and became a licensed professional engineer. He received his BS degree from the United States Military Academy at West Point. While at West Point, he was a Distinguished Graduate, Company Commander and varsity football Letterman. Mark has served on the Boards of both the Global Alliance for Medical Education and the West Point Society of New England.